Pulmonary Hypertension in the Intensive Care Unit

Area of Science:

• Cardiology
• Pulmonology
• Critical Care Medicine

Background:

• Pulmonary hypertension (PH) elevates pulmonary circulation pressure, potentially causing right ventricular (RV) failure.
• Patients can develop critical illness from PH complications or have PH secondary to critical illness.
• Accurate diagnosis is crucial, evaluating for common causes like left heart failure, lung disease, and pulmonary embolism.

Purpose of the Study:

• To outline the diagnostic considerations for pulmonary hypertension in critically ill patients.
• To discuss the management strategies for right ventricular failure in the context of PH.
• To clarify the role of specific pharmacologic treatment targeting the pulmonary vasculature.

Main Methods:

• Review of diagnostic approaches for PH, including evaluation of common etiologies.
• Analysis of management principles for RV failure, focusing on hemodynamic support.
• Assessment of criteria for initiating pharmacologic therapy directed at the pulmonary vasculature.

Main Results:

• Diagnostic workup should prioritize identifying underlying conditions such as left heart failure, hypoxemic lung disease, and pulmonary embolism.
• Management of RV failure involves optimizing preload, maintaining blood pressure, and using inotropes.
• Specific PH-targeted pharmacologic therapy is indicated for a select group after excluding left heart pressures and confirming elevated pulmonary vascular resistance.

Conclusions:

• Pulmonary hypertension and RV failure in critically ill patients pose significant risks.
• A thorough diagnostic evaluation is essential to guide appropriate management.
• Pharmacologic treatment of PH is reserved for specific cases after comprehensive assessment.